| 1 | 40 mg QD Alogabat | - | - | - | - | 1件: 201 201 💬
|
| 2 | 60 mg QD Alogabat | - | - | - | - | 1件: 201 201 💬
|
| 3 | 7 mg QD Alogabat | - | - | - | - | 1件: 201 201 💬
|
| 4 | Acylated and unacylated ghrelin dosages | 1件: Lenomorelin Lenomorelin | - | - | - | 3件: 193 193, 201, 202 💬
|
| 5 | Aknemin | - | - | - | - | 1件: 201 201 💬
|
| 6 | Aknemin 50 | - | - | - | - | 1件: 201 201 💬
|
| 7 | Alogabat | - | - | - | - | 1件: 201 201 💬
|
| 8 | Betaine | 1件: Betaine Betaine | 1件: Betaine
Betaine
💬
| - | - | 2件: 201 201, 337 💬
|
| 9 | CARBIDOPA | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 6 6, 13, 17, 90, 140, 164, 201 💬
|
| 10 | Creatine | 1件: Creatine Creatine | - | - | - | 11件: 1 1, 2, 5, 6, 8, 46, 49, 50, 113, 156, 201 💬
|
| 11 | Gaboxadol | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 201 201, 206 💬
|
| 12 | GABOXADOL MONOHYDRATE | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 13 | Gaboxadol monohydrate 0.5 mg | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 14 | Gaboxadol monohydrate 0.5 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 15 | Gaboxadol monohydrate 0.5 mg capsule | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 16 | Gaboxadol monohydrate 2 mg | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 17 | Gaboxadol monohydrate 2 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 18 | Gaboxadol monohydrate 2 mg capsule | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 19 | Gaboxadol monohydrate 5 mg | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 20 | Gaboxadol monohydrate 5 mg (intended commercial formulation) | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 21 | Ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 💬
|
| 22 | GTX-102 | 1件: GTX-102 GTX-102 | - | - | - | 2件: 65 65, 201 💬
|
| 23 | ION582 | - | - | - | - | 1件: 201 201 💬
|
| 24 | LEVODOPA | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 6件: 6 6, 17, 90, 140, 164, 201 💬
|
| 25 | Levodopa/Carbidopa (4:1) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 201 201 💬
|
| 26 | Metafolin | - | - | - | - | 1件: 201 201 💬
|
| 27 | Minocycline | 1件: Minocycline Minocycline | 1件: Minocycline
Minocycline
💬
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬
|
| 28 | Minocycline Hydrochloride | 1件: Minocycline Minocycline | 1件: Minocycline
Minocycline
💬
| - | - | 4件: 13 13, 201, 206, 299 💬
|
| 29 | NNZ-2591 | 1件: NNZ-2591 NNZ-2591 | - | - | - | 1件: 201 201 💬
|
| 30 | Non disponibile | - | - | - | - | 1件: 201 201 💬
|
| 31 | Nutritional Formulation Containing Exogenous Ketones | - | - | - | - | 1件: 201 201 💬
|
| 32 | OV101 | - | - | - | - | 2件: 201 201, 206 💬
|
| 33 | OV101 Regimen 1 | - | - | - | - | 1件: 201 201 💬
|
| 34 | OV101 regimen 2 | - | - | - | - | 1件: 201 201 💬
|
| 35 | Part 2 Adult Alogabat High Dose (aged 15-17) | - | - | - | - | 1件: 201 201 💬
|
| 36 | RO7248824 | - | - | - | - | 1件: 201 201 💬
|
| 37 | RO7248824/F02-01 | - | - | - | - | 1件: 201 201 💬
|
| 38 | RO7248824/F03-01 (Diluent for RO7248824/F02-01 | - | - | - | - | 1件: 201 201 💬
|
| 39 | Vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: Cyanocobalamin
Cyanocobalamin
,
Cyanocobalamin Co 57
,
Cyanocobalamin Co 58
,
Cyanocobalamin Co 60
💬
| - | - | 4件: 6 6, 201, 229, 299 💬
|